Recall of Hospira Injections

Hospira is voluntarily recalling one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL)and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 mg/mL), according to the FDA. The recall follows a confirmed vial defect. Glass particulate matter (glass strands) were found to have become affixed to the inside of vial walls. The glass particulate might dislodge into the solution. There have been no reports of adverse effects associated with the lots in question. Read more.

More News:

All news »

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments